Washington is currently home to 1697 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Seattle, Spokane, Tacoma and Vancouver. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Unobtrusive Sensing of Medication Intake ("USE-MI")
NCT03571022
Recruiting
The purpose of this study is to test the USE-MI system hardware and software to see if it can accurately measure when subjects take their HIV-related medications and help them remember to take these medications. With the use of a smartwatch and smartphone "app", investigators hope to be able to monitor medication adherence in real-time and send subjects electronic reminders when they may have forgotten to take their medication.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/21/2022
Locations: Swedish Medical Center, Seattle, Washington
Conditions: Medication Adherence
Register for Updates
Brain-Physical Optimization Conditioning
NCT04863469
Recruiting
Brain-Physical Optimization Conditioning (B-POC) aims to enhance physical performance by expanding the traditional focus of endurance training from purely physical training to the domain of cognitive endurance (Staiano et al., 2015; Dallaway et al., 2017). The current study seeks to isolate neurocognitive mechanisms of performance, particularly under high stress (e.g., physical or cognitive load) conditions, and to develop corresponding cognitive optimization tools.
Gender:
ALL
Ages:
Between 18 years and 40 years
Trial Updated:
03/25/2022
Locations: Medical Research Directorate - West, Tacoma, Washington
Conditions: Physical Performance
Register for Updates
Modifiable Variables in Parkinsonism (MVP)
NCT02194816
Recruiting
We are trying to identify factors associated with improved quality of life and fewer PD symptoms. We are attempting to identify practices, beliefs, and therapies used by individuals who report excellent quality of life, few PD symptoms, and reduced rates of progression. After agreeing to participate, we will ask participants to fill our questionnaires about their experience with PD, their health in general, along with their food intake every six months for five years.
Gender:
ALL
Ages:
19 years and above
Trial Updated:
03/10/2022
Locations: Bastyr University, Kenmore, Washington
Conditions: Parkinson's Disease, Parkinsonism, MSA - Multiple System Atrophy, Progressive Supranuclear Palsy, Shy-Drager Syndrome, Corticobasal Degeneration, Dementia With Lewy Bodies, Pick Disease, Olivopontocerebellar Atrophies
Register for Updates
SpeeDx Ciprofloxacin gyrA Assay for N. Gonorrhoeae Gonococcal Infection
NCT05286931
Recruiting
This study aims to test the effectiveness of using of SpeeDx Resistance Plus assay to guide treatment of Neisseria gonorrhoeae (Ng) in a sexual health clinic setting.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/09/2022
Locations: Public Health -- Seattle & King County Sexual Health Clinic, Seattle, Washington
Conditions: Neisseria Gonorrhoeae Infection
Register for Updates
Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension
NCT05277870
Recruiting
The purpose of this study is to evaluate the safety, efficacy, and usability of an eyedrop bottle adaptor that creates smaller eyedrops, Nanodropper, in an open-angle glaucoma/ocular hypertension patient population.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/03/2022
Locations: University of Washington, Seattle, Washington
Conditions: Glaucoma, Open-Angle, Ocular Hypertension
Register for Updates
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL
NCT05211856
Recruiting
The purpose of this study is to evaluate the efficacy and safety of acalabrutinib in combination with venetoclax and acalabrutinib in combination with venetoclax with and without obinutuzumab compared to chemoimmunotherapy in subjects with previously untreated CLL.
Gender:
All
Ages:
Between 18 years and 130 years
Trial Updated:
01/14/2022
Locations: Research Site, Seattle, Washington
Conditions: Chronic Lymphocytic Leukemia
Register for Updates
Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19
NCT04380870
Recruiting
The purpose of the study is to design and execute a prospective, longitudinal, descriptive cohort study in a pragmatic clinical practice for adults with symptoms that may be related to COVID-19.
Gender:
ALL
Ages:
Between 18 years and 114 years
Trial Updated:
09/27/2021
Locations: Seattle Intstitute of East Asian Medicine, Seattle, Washington
Conditions: Coronavirus Infection
Register for Updates
Fecal Microbiota Transplantation as a Strategy to Eradicate Resistant Organisms
NCT02543866
Recruiting
This protocol will evaluate fecal microbiota transplantation (FMT) as a strategy to eradicate intestinal colonization of extended-spectrum resistant (ESC-R) Enterobacteriaceae in pediatric patients. FMT will be performed on subjects with a history of at least one infection due to ESC-R Enterobacteriaceae. This protocol aims to determine the feasibility, safety, tolerability, and potential efficacy of FMT in pediatric patients with a history of ESC-R Enterobacteriaceae.
Gender:
ALL
Ages:
Between 7 years and 21 years
Trial Updated:
09/22/2021
Locations: Seattle Children's Hospital, Seattle, Washington
Conditions: Infection Resistant to Drugs
Register for Updates
Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
NCT02537769
Recruiting
The use of implantable left ventricular assist devices (LVAD) has increased over the last decade; partly because the newer continuous flow pumps feature a smaller design and better durability. These pumps have shown improved outcomes for those patients who don't qualify for heart transplantation and receive the LVAD device as a permanent therapy or a bridge to heart transplantation. Despite these improved outcomes, procedure related length of hospitalization for LVAD implantation is still 2 or 3... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/19/2021
Locations: University of Washington Medical Center, Seattle, Washington
Conditions: Tricuspid Regurgitation, Heart Failure NYHA Class III, Heart Failure NYHA Class IV
Register for Updates
An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT04718818
Recruiting
The present study D5272C00001 (Legacy # 3151-201-008) seeks to evaluate the efficacy and safety of brazikumab versus placebo in patients with moderately to severely active UC and will include assessments of clinical responses as demonstrated by improvement of symptoms and of colonic mucosal appearance as observed on endoscopy.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
01/19/2021
Locations: Research Site, Seattle, Washington
Conditions: Ulcerative Colitis
Register for Updates
Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial
NCT04704297
Recruiting
Rationale: Low back pain (LBP), or myofascial pain syndrome (MPS) of the low back, accounts for approximately 2.63 million visits in the United States, or 2.3 percent of annual Emergency Department (ED) visits. An estimated 100 billion dollars per year is lost from LBP. Approximately one-third of this is direct costs. Previous studies have established the safety of trigger point injections (TPI). However, the results of these studies are highly heterogeneous regarding TPI's ability to treat pain... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/09/2021
Locations: Department of Emergency Medicine, Madigan Army Medical Center, Tacoma, Washington
Conditions: Low Back Pain, Myofascial Pain Syndrome Lower Back
Register for Updates
VENOUS: A Translational Study of Enterococcal Bacteremia
NCT04410276
Recruiting
The purpose of this study is to assemble a multicenter prospective cohort of patients with enterococcal bloodstream infections (BSIs) to provide data on outcomes of patients with enterococcal BSIs for sample size calculations for future trials, as well as to characterize enterococcal isolates causing BSIs in order to comprehensively dissect the molecular epidemiology of infecting organisms for future studies.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/26/2020
Locations: Fred Hutchinson Cancer Research Center, Seattle, Washington
Conditions: Enterococcal Bacteremia
Register for Updates